Fundraising Fox
Aclarion
NASDAQ: ACONBroomfield, US · Founded 2015 · Delaware corporation · 15 employees on LinkedIn
Find your way into Aclarion
334 people in our graph share verified history with the Aclarion team — schools, employers, funds. One of them is your warm intro.
Jim Peacockunlockedknows Brent Ness · together at Aclarion (overlapped)
×3knows the team · via First Union Securities
×4knows the team · via Cleerly
knows the team · via CH2M
knows the team · via Nuvasive
×2knows the team · via Arthur Andersen & Co.
Aclarion develops NOCISCAN, a SaaS platform that uses MR spectroscopy to noninvasively help physicians distinguish painful from nonpainful spinal discs in patients with chronic low back pain. It complements conventional lumbar MRI with pain biomarker data and per-disc NOCI+/NOCI- scores to support treatment and surgical planning.
Founders & leadership
Aclarion was founded in 2015 by Jeffrey Thramann.
JT
Jeffrey ThramannFounder
BN
Brent NessPresident and Chief Executive OfficerBrent Ness is CEO of Aclarion, a MedTech company developing NOCISCAN, a SaaS platform that uses MR spectroscopy to help physicians identify painful spinal discs in patients with chronic low back pain. He has over 25 years of experience in healthcare and medtech leadership roles across startups and established companies.
GG
Gregory GouldChief Financial OfficerGregory Gould is Chief Financial Officer at Aclarion, which develops a SaaS platform using MR spectroscopy to help physicians identify painful spinal discs in patients with chronic low back pain. He has extensive finance leadership experience, including directing accounting and finance functions, managing M&A and restructurings, and overseeing over $500 million in equity and debt financings across multiple organizations.
RB
Ryan BondChief Strategy OfficerChief Strategy Officer of Aclarion, Ryan Bond brings experience across healthcare, financial services, and engineering sectors with expertise in business development, strategy, and cross-functional team leadership.
JC
James C Peacock IIINamed on SEC filing
Board
SD
Stephen DeitschBoard director
SB
Scott BreidbartBoard director
AW
Amanda WilliamsBoard director
WG
William Gerard WesemannBoard director
DN
David NealBoard director
RE
Robert EastlackBoard director
Reported raises · per SEC filings
Form D private placements$11.7M disclosed across 6 rounds · 2015–2024
▶$1MraisedOct 2024 · 3 investors · OtherRule 506(b)
▶$1MraisedOct 2024 · 3 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- John LorbieckiExecutive Officer
- Stephen DeitschDirector
- Scott BreidbartDirector
- Amanda WilliamsDirector
- William Gerard WesemannDirector
- David NealDirector
- Brent NessExecutive Officer, Director
- Jeffrey ThramannExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $1M
- Minimum investment
- $200K
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2MraisedMay 2023 · 2 investors · OtherRule 506(b)
▶$2MraisedMay 2023 · 2 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey ThramannExecutive Officer, Director
- John LorbieckiExecutive Officer
- Brent NessExecutive Officer, Director
- Amanda WilliamsDirector
- David NealDirector
- Stephen DeitschDirector
- Scott BreidbartDirector
- William Gerald WesemannDirector
- Offering amount
- $2M
- Amount sold
- $2M
- Minimum investment
- $289K
- Sales commissions
- $220K
- Placement agents
- Carter, Terry & Company, Inc, Maxim Group LLC
- First sale
- May 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2MraisedOct 2021 · 4 investors · OtherRule 506(b)
▶$2MraisedOct 2021 · 4 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- John LorbieckiExecutive Officer
- Robert EastlackDirector
- Brent NessExecutive Officer, Director
- David K NealDirector
- Lawrence TannenbaumDirector
- Jeffrey ThramannDirector
- William Gerard WesemannDirector
- Jeffrey LotzDirector
- Offering amount
- $2M
- Amount sold
- $2M
- Minimum investment
- $30K
- Sales commissions
- $300K
- Proceeds to insiders
- $300K
- Placement agents
- Nocimed
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.4MraisedMar 2020 · 12 investors · OtherRule 506(b)
▶$1.4MraisedMar 2020 · 12 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Brett LanutiExecutive Officer, Director
- Robert EastlackDirector
- William Gerald WesemannDirector
- Jeffrey LotzDirector
- David K NealDirector
- Michael HarshDirector
- Offering amount
- $2.5M
- Amount sold
- $1.4M
- First sale
- Feb 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.3MraisedMay 2018 · 14 investors · Other Health CareRule 506(b)
▶$3.3MraisedMay 2018 · 14 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- James C Peacock IIIExecutive Officer, Director
- William WesemannDirector
- Brett LanutiExecutive Officer, Director
- David NealDirector
- Lothar KoobDirector
- Robert EastlackDirector
- Offering amount
- $4M
- Amount sold
- $3.3M
- First sale
- Jul 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$2MraisedMar 2015 · 1 investors · Other Health CareRule 506(b)
▶$2MraisedMar 2015 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Robert EastlackDirector
- James C Peacock IIIExecutive Officer, Director
- Augustus DenisDirector
- Offering amount
- $5M
- Amount sold
- $2M
- Proceeds to insiders
- $175K
- First sale
- Feb 2015
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
BirdEye17 shared keywordsBirdeye offers an AI-powered platform with multi-agent "AI Coworkers" that handle marketing, operations, and customer experience tasks such as search optimization, review generation, listings management, social posting, and front-desk coordination. It serves multi-location businesses, providing a unified view of customers, locations, and interactions.
Buoy Health15 shared keywordsBuoy Health offers an AI-based symptom checker that asks users questions to help identify possible health issues and guides them toward appropriate care, products, or providers. It also publishes health content reviewed by clinicians such as doctors, nurses, and therapists.
Companies competing with Aclarion for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Aclarion do?
- Aclarion develops NOCISCAN, a SaaS platform that uses MR spectroscopy to noninvasively help physicians distinguish painful from nonpainful spinal discs in patients with chronic low back pain. It complements conventional lumbar MRI with pain biomarker data and per-disc NOCI+/NOCI- scores to support treatment and surgical planning.
- Who founded Aclarion?
- Aclarion was founded by Jeffrey Thramann in 2015.
- How much funding has Aclarion raised?
- Aclarion has disclosed $11.7M raised across 6 rounds.
- Where is Aclarion headquartered?
- Aclarion is headquartered in Broomfield, US.